Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01606878
Title Crizotinib and Combination Chemotherapy in Treating Younger Patients With Relapsed or Refractory Solid Tumors or Anaplastic Large Cell Lymphoma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Children's Oncology Group

Advanced Solid Tumor

anaplastic large cell lymphoma


Dexamethasone + Doxorubicin + Vincristine Sulfate

Cyclophosphamide + Topotecan


Age Groups: child
Covered Countries USA | CAN

No variant requirements are available.